Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.37 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.37 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.37 |
| ▸ | LTK | P29376 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3511045 | 0.94 | METAP2 (0.43) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL4081786 | 0.91 | CA12 (0.44) | ENPP1TNFALDH1A1HSD17B10HPGD | |
| SCHEMBL18905752 | 0.90 | ENPP1 (0.44) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL13085142 | 0.90 | MAPK1 (0.44) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL16485032 | 0.90 | CYP1A2 (0.44) | ENPP1PARP1KEAP1NFE2L2MAP4K4 | |
| SCHEMBL11888000 | 0.90 | ENPP1 (0.37) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL14226899 | 0.90 | ENPP1 (0.44) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL3223984 | 0.90 | MAPK1 (0.44) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL13085213 | 0.88 | CA12 (0.40) | ENPP1PARP1CRHBPCRHR2KEAP1 | |
| SCHEMBL13492559 | 0.88 | ENPP1 (0.43) | ENPP1PARP1CRHBPCRHR2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2085371-B1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING THE FLUORANTHENE COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | IDEMITSU KOSAN CO (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-9120748-B2 | Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| EP-2085371-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING THE FLUORANTHENE COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | Idemitsu Kosan Co., Ltd. (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | LEF1, ESD, AFF2 | ENPP1 553/4885PARP1 1670/4885CRHBP 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.